Cargando…
Automation of Infectious Focus Assay for Determination of Filovirus Titers and Direct Comparison to Plaque and TCID(50) Assays
Ongoing efforts to develop effective therapies against filoviruses rely, to different extents, on quantifying the amount of viable virus in samples by plaque, TCID(50), and focus assays. Unfortunately, these techniques have inherent variance, and laboratory-specific preferences make direct compariso...
Autores principales: | Keiser, Patrick T., Anantpadma, Manu, Staples, Hilary, Carrion, Ricardo, Davey, Robert A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826780/ https://www.ncbi.nlm.nih.gov/pubmed/33445537 http://dx.doi.org/10.3390/microorganisms9010156 |
Ejemplares similares
-
Comparison among plaque assay, tissue culture infectious dose (TCID(50)) and real-time RT-PCR for SARS-CoV-2 variants quantification
por: Zapata-Cardona, Maria Isabel, et al.
Publicado: (2022) -
Standardization of the Filovirus Plaque Assay for Use in Preclinical Studies
por: Shurtleff, Amy C., et al.
Publicado: (2012) -
Validation of the Filovirus Plaque Assay for Use in Preclinical Studies
por: Shurtleff, Amy C., et al.
Publicado: (2016) -
Monte Carlo simulation of the Spearman-Kaerber TCID50
por: Wulff, Niels H, et al.
Publicado: (2012) -
Time to revisit the endpoint dilution assay and to replace the TCID(50) as a measure of a virus sample’s infection concentration
por: Cresta, Daniel, et al.
Publicado: (2021)